Polycystic ovary syndrome (PCOS) is the most common syndrome related to excessive hair growth. It affects an estimated 10 to 13% of women of reproductive age worldwide, and up to 70% of those women don’t know they have it. The hallmark hair-related symptom is hirsutism: thick, dark hair growing in areas typically associated with male-pattern hair, such as the face, chest, and abdomen.
How PCOS Triggers Excess Hair Growth
PCOS causes the body to produce higher-than-normal levels of androgens, sometimes called “male hormones,” though all women produce them in small amounts. When androgen levels rise, they act on hair follicles in specific parts of the body and transform fine, nearly invisible hairs into thicker, darker, coarser ones. This transformation happens because androgens extend the active growth phase of the hair cycle, giving follicles more time to enlarge with each cycle. Over successive cycles, the follicles keep getting bigger and producing progressively thicker hair.
This process tends to be most noticeable on the upper lip, chin, chest, lower abdomen, and upper back. The severity of hair growth is closely tied to how high androgen levels are, and symptoms tend to be more pronounced in people with obesity. That connection isn’t random: excess weight promotes insulin resistance, which causes the body to produce more insulin. Elevated insulin, in turn, signals the body to produce even more androgens, creating a cycle that worsens hirsutism over time.
Other Syndromes That Cause Abnormal Hair Growth
While PCOS dominates the list, it isn’t the only syndrome involved. Cushing’s syndrome, caused by prolonged exposure to high cortisol levels, also produces hirsutism. Women and children with Cushing’s syndrome typically develop fine downy facial hair along with acne, and may experience thinning at the temples. The hair growth in Cushing’s is driven by increased adrenal androgen and cortisol secretion, and it usually appears alongside other distinctive signs like purple stretch marks and easy bruising.
There’s also an important distinction between hirsutism and a separate condition called hypertrichosis. Hirsutism refers specifically to women growing thick hair in androgen-sensitive areas, and it’s almost always hormonal. Hypertrichosis is excessive hair growth anywhere on the body, in either sex, and it’s usually not driven by hormones. Rare genetic syndromes cause hypertrichosis, including Ambras syndrome (a congenital condition causing hair growth over nearly the entire body), Cornelia de Lange syndrome, Cantú syndrome, and more than a dozen others. These are uncommon enough that most people searching about hair growth syndromes are dealing with something hormonal, most likely PCOS.
How PCOS Is Diagnosed
Doctors use what’s known as the Rotterdam criteria, which require at least two of three features: signs of excess androgens (either through blood tests or visible symptoms like hirsutism), irregular or absent ovulation, and a specific appearance of the ovaries on ultrasound. Other conditions that could explain the symptoms need to be ruled out first.
To assess hirsutism specifically, clinicians use the Ferriman-Gallwey scoring system. It evaluates hair density across 11 body areas, including the lip, chin, chest, upper and lower abdomen, thighs, and back. Each area is scored from 0 (no excess hair) to 4 (extensive growth), for a maximum possible score of 44. A total score of 8 or higher is considered diagnostic for hirsutism. This threshold was originally set based on the 95th percentile of hair growth data in women, meaning only about 5% of women without a hormonal condition would score that high.
Managing Hair Growth in PCOS
Treatment typically starts with combined oral contraceptives (birth control pills containing both estrogen and progestin). These work by lowering the amount of free androgens circulating in the body. The Endocrine Society’s clinical guidelines recommend oral contraceptives as initial therapy for most women with hirsutism who aren’t trying to conceive, and note that no single brand appears to be more effective than another for this purpose. Women at higher risk for blood clots, including those over 39 or with obesity, are generally started on formulations with lower estrogen doses.
If hair growth hasn’t improved enough after six months on birth control, an anti-androgen medication is typically added. This class of drug blocks androgens from acting on hair follicles. Women taking it generally see a halt in further darkening and coarsening of hair, a slower growth rate, and thinner hair shafts over time. The key expectation to set is that hormonal treatment slows and reduces new growth but doesn’t eliminate hair that’s already there. That’s where physical removal methods come in.
Electrolysis vs. Laser Hair Removal
Both electrolysis and laser hair removal are widely used alongside hormonal treatment. Electrolysis, which destroys individual follicles with an electric current, has shown superior long-term results for permanent hair removal in hormonally sensitive facial areas and works across all skin types. Laser hair removal is faster per session but carries a notable risk for women with PCOS: it can sometimes trigger paradoxical hair growth, where treated areas actually develop new or thicker hair. Although electrolysis requires more sessions overall, it tends to be more reliable and cost-effective as a permanent solution for PCOS-related facial hair.
The Insulin Connection
One of the most practical things to understand about PCOS-related hair growth is that it doesn’t exist in isolation. The same insulin resistance that drives excess androgen production also raises the risk of type 2 diabetes, cardiovascular disease, and metabolic syndrome. This means that interventions targeting insulin resistance, particularly weight management and physical activity, can meaningfully reduce androgen levels and slow hair growth. For many women, even modest weight loss improves hormonal balance enough to see a difference in symptoms. Addressing insulin resistance doesn’t just help with hair; it changes the trajectory of the syndrome as a whole.